We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

RecipharmCobra Biologics Announces Granted Patents on its Bacterial Genetic Modification Technology (Xer-cise™)

News   Feb 08, 2011

 
RecipharmCobra Biologics Announces Granted Patents on its Bacterial Genetic Modification Technology (Xer-cise™)
 
 
 

RELATED ARTICLES

Gene Therapy Restores Immunity in Infants With Rare Immunodeficiency Disease

News

A small clinical trial has shown that gene therapy can safely correct the immune systems of infants newly diagnosed with a rare, life-threatening inherited disorder in which infection-fighting immune cells do not develop or function normally.

READ MORE

The Leukemia Atlas: A Guide to Proteins That Signal Disease

News

Only about one in four people diagnosed with acute myelogenous leukemia (AML) survive five years after the initial diagnosis. To improve that survival rate, researchers have created an online atlas to identify and classify protein signatures present at AML diagnosis.

READ MORE

Creating a Catalog of Individual Genomic Differences

News

There are hundreds of thousands of structural variants (SVs) in the human genome that are hard to identify than single nucleotide variants. Researchers have used a full suite of genomic technologies to analyze the number of SVs in three individuals, and the results present as the most comprehensive catalog of SVS to date.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE